Former EVP, Chief Financial Officer and Treasurer · Anika Therapeutics, Inc. (ANIK)

Michael Levitz

A named executive officer of Anika Therapeutics in every fiscal year CompBrief holds from FY2020 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$1,774,860

Salary $514,582Stock awards $542,610Bonus $100,000

FY2023: $1,651,818

3rd of 5 named executive officers at Anika Therapeutics by FY2024 total.

5 named officers on file for Anika Therapeutics, FY2024

Michael Levitz’s pay file — $29

  • 5 fiscal years of pay, line by line
  • 7 equity grants, each cited to its filing
  • ANIK’s disclosed peer group of 17 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Anika Therapeutics’s whole pay program stands against its peers

  • Anika Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ANIK→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2025 (DEF 14A).

Free

Get Michael Levitz’s full pay file as a PDF — free

More than this page: up to 10 years of Michael’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Michael Levitz compensation by year

Anika Therapeutics Summary Compensation Table · all 5 fiscal years held
In US dollars, as Anika Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021FY2022FY2023FY2024
Salary$173,077$456,400$474,600$496,000$514,582
Bonus$73,601$205,362$213,570$213,380$100,000
Stock awards$799,971$452,710$682,065$474,262$542,610
Option awards$799,993$453,004$433,721$443,420$541,733
Non-equity incentive$0$0$0$0$0
Pension and deferred compensation$0$0$0$0$0
All other$11,318$21,380$22,430$24,756$75,935
Total$1,857,960$1,588,856$1,826,386$1,651,818$1,774,860

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Anika Therapeutics, Inc. DEF 14A filed April 28, 2025, accession 0001140361-25-016082, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Anika Therapeutics, Inc. filed document, accession 0001140361-25-016082. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2025.

$1.9M
$1.6M
$1.8M
$1.7M
$1.8M
FY20
FY21
FY22
FY23
FY24
SalaryBonusStock awardsOption awardsAll other

Anika Therapeutics’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Cheryl BlanchardPresident and Chief Executive Officer$5,103,466
Stephen GriffinEVP, Chief Financial Officer and Treasurer$2,646,150
Michael Levitz · this pageFormer EVP, Chief Financial Officer and Treasurer$1,774,860
David ColleranEVP, General Counsel and Secretary$1,668,587
Anne NunesSVP, Chief Operations Officer$1,131,633

The full Anika Therapeutics compensation record

free company brief

This page is one person within Anika Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Anika Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Anika Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Michael Levitz's compensation dossier · One-time report. No refunds.